Integrated Filing — IndAS



General information about company

Scrip Code 544279
NSE Symbol GODAVARIB
MSEI Symbol NOTLISTED
ISIN INE497S01012
Name of company GODAVARI BIOREFINERIES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 11-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 01-11-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 11-11-2025   11:30:00
End date and time of board meeting 11-11-2025   17:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 08-02-2025
Indicate Company website link for updated RPT policy of the Company www.godavaribiorefineries.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
there is no default on loan by the entity during the quarter and half year



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 42,280.86 94,593.30
Other income 330.74 390.10
Total income 42,611.60 94,983.40
2 Expenses
(a) Cost of materials consumed 14,600.11 35,126.53
(b) Purchases of stock-in-trade 197.63 383.35
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 18,932.87 40,601.06
(d) Employee benefit expense 3,050.71 6,167.53
(e) Finance costs 1,221.65 2,718.86
(f) Depreciation, depletion and amortisation expense 1,347.26 2,692.64
(f) Other Expenses
1 Stores and Spare consumed 618.69 1,378.88
2 Power and Fuel 2,187.93 4,361.43
3 Packing, Forwarding and Storage 533.85 1,033.44
4 Repairs & Maintenance 1,366.52 2,091.77
5 Selling Expenses 695.88 1,662.58
6 Rent , Rates and Taxes 83.04 170.81
7 Insurance 157.64 303.25
8 Professional Charges 169.10 308.74
9 General Expenses (Including travelling,telephone, etc.) 589.51 1,424.69
10 Audit Fees and Tax Audit Fees & Other Expenses 11.50 23.00
Total other expenses 6,413.66 12,758.59
Total expenses 45,763.89 1,00,448.56
3 Total profit before exceptional items and tax (3,152.29) (5,465.16)
4 Exceptional items (2,665.59) (2,665.59)
5 Total profit before tax (5,817.88) (8,130.75)
6 Tax expense
7 Current tax 4.45 4.45
8 Deferred tax (1,559.63) (2,208.10)
9 Total tax expenses (1,555.18) (2,203.65)
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations (4,262.70) (5,927.10)
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period (4,262.70) (5,927.10)
17 Other comprehensive income net of taxes (157.40) (157.40)
18 Total Comprehensive Income for the period (4,420.10) (6,084.50)
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 5,117.60 5,117.60
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations -8.33 -11.58
Diluted earnings (loss) per share from continuing operations -8.33 -11.58
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations -8.33 -11.58
Diluted earnings (loss) per share from continuing and discontinued operations -8.33 -11.58
24 Debt equity ratio 1.05 1.05
25 Debt service coverage ratio -0.60 -0.12
26 Interest service coverage ratio -12.74 -9.70
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) The neighbouring sugar mills have agreed to pay additional harvesting charges to contractors for the season 2023-2024, thus, in order to remain competitive, the Company has decided that it will also pay additional harvest charges related to the 2023-2024 sugar season. Accordingly, the Company has recognized and decided to provide for an exceptional expense amounting to Rs 2665.59 lakhs.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 84,136.55
Capital work-in-progress 8,172.41
Investment property 0.00
Goodwill 0.00
Other intangible assets 97.27
Intangible assets under development 1,733.40
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 1,609.44
Trade receivables, non-current 203.00
Loans, non-current 951.00
Other non-current financial assets 1,464.81
Total non-current financial assets 4,228.25
Deferred tax assets (net) 0.00
Other non-current assets 1,572.19
Total non-current assets 99,940.07
2 Current assets
Inventories 20,283.86
Current financial asset
Current investments 0.00
Trade receivables, current 7,941.12
Cash and cash equivalents 186.88
Bank balance other than cash and cash equivalents 2,422.05
Loans, current 0.00
Other current financial assets 1,455.94
Total current financial assets 12,005.99
Current tax assets (net) 0.00
Other current assets 12,338.42
Total current assets 44,628.27
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 1,44,568.34
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 5,117.60
Other equity 66,056.79
Total equity attributable to owners of parent 71,174.39
Non controlling interest
Total equity 71,174.39
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 32,760.73
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities 200.83
Total non-current financial liabilities 32,961.56
Provisions, non-current 183.82
Deferred tax liabilities (net) 2,091.90
Deferred government grants, Non-current 0.00
Other non-current liabilities 39.94
Total non-current liabilities 35,277.22
Current liabilities
Current financial liabilities
Borrowings, current 16,205.91
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 840.24
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 15,979.81
Total Trade payable 16,820.05
Other current financial liabilities 3,912.51
Total current financial liabilities 36,938.47
Other current liabilities 695.42
Provisions, current 482.84
Current tax liabilities (Net) 0.00
Deferred government grants, Current 0.00
Total current liabilities 38,116.73
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 73,393.95
Total equity and liabilites 1,44,568.34
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Sugar 18,124.35 40,233.93
2 Cogeneration 0.0076891 3,332.13
3 Bio based Chemicals 14,499.52 28,400.45
4 Distlliery 10,142.77 30,843.11
Total Segment Revenue 43,535.55 1,02,809.62
Less: Inter segment revenue 1,254.69 8,216.32
Revenue from operations 42,280.86 94,593.30
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Sugar (4,547.38) (5,996.02)
2 Cogeneration (1,060.19) (1,976.08)
3 Bio based Chemicals 1,135.77 2,041.88
4 Distlliery (19.72) 795.68
Total Profit before tax (4,491.52) (5,134.54)
i. Finance cost 1,221.65 2,718.86
ii. Other Unallocable Expenditure net off Unallocable income 104.71 277.35
Profit before tax (5,817.88) (8,130.75)
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Sugar 44,602.89 44,602.89
2 Cogeneration 8,723.77 8,723.77
3 Bio based Chemicals 45,497.15 45,497.15
4 Distlliery 45,663.67 45,663.67
Total Segment Asset 1,44,487.48 1,44,487.48
Un-allocable Assets 80.86 80.86
Net Segment Asset 1,44,568.34 1,44,568.34
4 Segment Liabilities
Segment Liabilities
1 Sugar 35,247.28 35,247.28
2 Cogeneration 1,167.02 1,167.02
3 Bio based Chemicals 17,234.88 17,234.88
4 Distlliery 17,652.86 17,652.86
Total Segment Liabilities 71,302.04 71,302.04
Un-allocable Liabilities 2,091.90 2,091.90
Net Segment Liabilities 73,393.94 73,393.94
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 157.40 157.40
5 Total Other comprehensive income (157.40) (157.40)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax (8,130.75)
Adjustments for reconcile profit (loss)
Adjustments for finance costs 2,718.86
Adjustments for decrease (increase) in inventories 52,976.74
Adjustments for decrease (increase) in trade receivables, current 5,220.28
Adjustments for decrease (increase) in trade receivables, non-current 85.18
Adjustments for decrease (increase) in other current assets 122.85
Adjustments for decrease (increase) in other non-current assets (2,336.94)
Adjustments for other financial assets, non-current (253.73)
Adjustments for other financial assets, current (146.27)
Adjustments for other bank balances (509.40)
Adjustments for increase (decrease) in trade payables, current (36,271.65)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (5,395.77)
Adjustments for increase (decrease) in other non-current liabilities (3.01)
Adjustments for depreciation and amortisation expense 2,692.64
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current (20.25)
Adjustments for provisions, non-current (134.78)
Adjustments for other financial liabilities, current (20.01)
Adjustments for other financial liabilities, non-current (5.02)
Adjustments for unrealised foreign exchange losses gains (84.36)
Adjustments for dividend income 0.00
Adjustments for interest income 112.89
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) (94.03)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items (138.72)
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 18,289.72
Net cash flows from (used in) operations 10,158.97
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) (73.63)
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 10,232.60
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 266.93
Purchase of property, plant and equipment 6,979.07
Proceeds from sales of investment property 0.00
Purchase of investment property 5.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 919.43
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 100.01
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) investing activities (7,536.56)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 10,403.75
Repayments of borrowings 10,023.66
Payments of lease liabilities 10.99
Dividends paid 0.00
Interest paid 3,028.13
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (2,659.03)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 37.01
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 37.01
Cash and cash equivalents cash flow statement at beginning of period 149.87
Cash and cash equivalents cash flow statement at end of period 186.88





Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising Public Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 30-10-2024
Amount Raised 32,500.00
Report filed for Quarter ended 30-09-2025
Monitoring Agency Applicable
Monitoring Agency Name, if applicable CARE RATING LIMITED
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NA
Comments of the Audit Committee after review NA
Comments of the auditors, if any NA
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Repayment of Loan NA 24,000.00 0.00 24,000.00 0.00
2 General Corporate Purpose NA 6,361.00 6,507.00 6,501.00 0.00
3 Issue Expenditure NA 2,319.00 1,993.00 1,784.00 0.00 In Q2 FY26, the company has transferred Rs. 0.05 crore from the public issue account to monitoring account and further to the CC account from where it has been transferred to vendors for issue expenses. The same has been verified from bank statements and supporting invoices. Out of the total issue expense of Rs. 0.05 crore, Rs. 0.01 crore is the reimbursed expense, the payment of the same has been verified from the bank statement and invoice.


Signatory Details

Name of signatory Manoj Jain
Designation of person Company Secretary and Compliance Officer
Place Sakarwadi, Maharashtra
Date 11-11-2025




Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Godavari Biorefineries Limited Solar Magic Private Limited Wholly Owned Subsidiary Any other transaction Loan Omnibus Approval 919.44 31.56 951.00
2 Godavari Biorefineries Limited Solar Magic Private Limited Wholly Owned Subsidiary Interest received Omnibus Approval 17.04 0.00 0.00
3 Godavari Biorefineries Limited Solar Magic Private Limited Wholly Owned Subsidiary Purchase of goods or services Omnibus Approval 41.85 (22.85) 1.07
4 Godavari Biorefineries Limited Solar Magic Private Limited Wholly Owned Subsidiary Sale of goods or services Omnibus Approval 14.89 0.00 0.35
5 Godavari Biorefineries Limited Godavari Biorefineries INC. Wholly Owned Subsidiary Any other transaction Commission paid Omnibus Approval 46.10 26.62 45.77
6 Godavari Biorefineries Limited Godavari Biorefineries B.V. Wholly Owned Subsidiary Any other transaction Commission and reimbursements paid Omnibus Approval 58.20 49.23 61.30
7 Godavari Biorefineries Limited Godavari Biorefineries B.V. Wholly Owned Subsidiary Sale of goods or services Omnibus Approval 2,606.56 331.70 67.73
8 Godavari Biorefineries Limited The K.J.Somaiya Institute Applied Agricultural Research Enterprise over which Key Managerial Personnel of are able to exercise significant influence Purchase of goods or services Omnibus Approval 7.49 0.44 (9.07)
9 Godavari Biorefineries Limited Arpit Limited Promoter Group Purchase of goods or services Omnibus Approval 0.15 0.00 0.00
10 Godavari Biorefineries Limited Shree Girivanvasi Pragati Mandal Enterprise over which Key Managerial Personnel of are able to exercise significant influence Purchase of goods or services Omnibus Approval 1.57 0.30 0.27
11 Godavari Biorefineries Limited Girivanvasi Educational Trust Enterprise over which Key Managerial Personnel of are able to exercise significant influence Purchase of goods or services Omnibus Approval 0.31 0.00 0.00
12 Godavari Biorefineries Limited Acharya Travel Agency Enterprise over which Key Managerial Personnel of are able to exercise significant influence Purchase of goods or services Omnibus Approval 24.68 1.73 0.25
13 Godavari Biorefineries Limited Somaiya Agencies Pvt Ltd Promoter Purchase of goods or services Omnibus Approval 0.17 0.00 0.01
14 Godavari Biorefineries Limited Filmedia Communications System Private Limited Promoer Group Any other transaction Rent paid Omnibus Approval 107.62 0.00 0.00
15 Godavari Biorefineries Limited Somaiya Properties & Investments Private Limited Promoter Group Any other transaction Rent paid Omnibus Approval 8.42 0.00 0.00
16 Godavari Biorefineries Limited K. J.Somaiya & Sons Private Limited Promoter Group Any other transaction Royalty paid Omnibus Approval 104.22 46.60 42.55
17 Godavari Biorefineries Limited Filmedia Communications System Private Limited Promoter Group Purchase of goods or services Omnibus Approval 3.56 0.00 0.00
18 Godavari Biorefineries Limited Somaiya Vidyavihar Enterprise over which Key Managerial Personnel of are able to exercise significant influence Sale of goods or services Omnibus Approval 0.27 0.00 0.27
19 Godavari Biorefineries Limited The K.J.Somaiya Institute Applied Agricultural Research Enterprise over which Key Managerial Personnel of are able to exercise significant influence Sale of goods or services Omnibus Approval 0.55 0.00 0.02
20 Godavari Biorefineries Limited The K.J.Somaiya Institute Applied Agricultural Research Enterprise over which Key Managerial Personnel of are able to exercise significant influence Any other transaction Contribution paid Omnibus Approval 23.00 0.00 0.00
21 Godavari Biorefineries Limited Sangeeta A Srivastava Executive Director Any other transaction Fix Deposit Interest paid Omnibus Approval 1.72 0.00 0.00
22 Godavari Biorefineries Limited Sangeeta A Srivastava Executive Director Any other transaction FIX Deposit Receipt or Renewal Omnibus Approval 0.00 44.71 32.88
23 Godavari Biorefineries Limited Sangeeta A Srivastava Executive Director Any other transaction Fix Deposit repaid Omnibus Approval 10.00 44.71 32.88
24 Godavari Biorefineries Limited Bhalchandra R. Bakshi Executive Director Any other transaction Fix Deposit Interest paid Omnibus Approval 2.76 0.00 0.00
25 Godavari Biorefineries Limited Bhalchandra R. Bakshi Executive Director Any other transaction FIX Deposit Receipt or Renewal Omnibus Approval 6.65 58.13 58.58
26 Godavari Biorefineries Limited Bhalchandra R. Bakshi Executive Director Any other transaction Fix Deposit repaid Omnibus Approval 7.00 58.13 58.58
27 Godavari Biorefineries Limited Suhas U Godge Executive Director Any other transaction Fix Deposit Interest paid Omnibus Approval 2.97 0.00 0.00
28 Godavari Biorefineries Limited Suhas U Godge Executive Director Any other transaction FIX Deposit Receipt or Renewal Omnibus Approval 20.00 60.23 60.62
29 Godavari Biorefineries Limited Suhas U Godge Executive Director Any other transaction Fix Deposit repaid Omnibus Approval 16.85 60.23 60.62
30 Godavari Biorefineries Limited Naresh S Khetan CFO Any other transaction Fix Deposit Interest paid Omnibus Approval 15.65 0.00 0.00
31 Godavari Biorefineries Limited Naresh S Khetan CFO Any other transaction FIX Deposit Receipt or Renewal Omnibus Approval 84.00 318.00 306.25
32 Godavari Biorefineries Limited Naresh S Khetan CFO Any other transaction Fix Deposit repaid Omnibus Approval 95.75 318.00 306.25
33 Godavari Biorefineries Limited Samir S. Somaiya Promoter Remuneration NA 189.31 0.00 0.00
34 Godavari Biorefineries Limited Sangeeta A Srivastava Executive Director Remuneration NA 56.24 0.00 0.00
35 Godavari Biorefineries Limited Bhalchandra R. Bakshi Executive Director Remuneration NA 33.77 0.00 0.00
36 Godavari Biorefineries Limited Suhas U Godge Executive Director Remuneration NA 28.51 0.00 0.00
37 Godavari Biorefineries Limited Naresh S Khetan CFO Remuneration NA 63.83 0.00 0.00
38 Godavari Biorefineries Limited Sheyans S Gang Deputy CFO Remuneration NA 15.14 0.00 0.00
39 Godavari Biorefineries Limited Manoj Jain Company Secretary and Compliance officer Remuneration NA 17.36 0.00 0.00
40 Godavari Biorefineries Limited Swarna S Gunware Joint Compamy Secretary Remuneration NA 12.96 0.00 0.00
41 Godavari Biorefineries Limited Lakshmi Kantam Mannepalli Independent Director Any other transaction Director Sitting Fees NA 2.80 0.00 0.00
42 Godavari Biorefineries Limited Hemant Luthra Independent Director Any other transaction Director Sitting Fees NA 2.80 0.00 0.00
43 Godavari Biorefineries Limited Sanjay Puri Independent Director Any other transaction Director Sitting Fees NA 2.45 0.00 0.00
44 Godavari Biorefineries Limited Nitin Mehta Independent Director Any other transaction Director Sitting Fees NA 0.70 0.00 0.00
45 Godavari Biorefineries Limited Raman Ramachandran Non Executive Director Any other transaction Director Sitting Fees NA 1.05 0.00 0.00
46 Godavari Biorefineries Limited Kumar L.Desai Independent Director Any other transaction Director Sitting Fees NA 0.70 0.00 0.00
47 Godavari Biorefineries Limited Somaiya Vidyavihar Enterprise over which Key Managerial Personnel of are able to exercise significant influence Any other transaction Software application Development, Training Expenses paid,Professional fees, AMC Contract etc Omnibus Approval 3.19 0.00 0.00
48 Godavari Biorefineries Limited Somaiya Properties & Investments Private Limited Promoter Group Purchase of goods or services Omnibus Approval 0.00 (1.50) (1.50)
49 Godavari Biorefineries Limited Samir S. Somaiya Promoter and Director Any other transaction Other Credit Balance Omnibus Approval 0.00 1.36 1.36
50 Godavari Biorefineries B.V. Godavari Biorefineries INC. Wholly Owned Subsidiary Any other transaction Commission paid Omnibus Approval 0.00 5.03 0.00
51 Cayugs Investments B.V. Godavari Biorefineries B.V. Wholly Owned Subsidiary Loan Omnibus Approval 1.43 86.51 89.81
52 Cayugs Investments B.V. Godavari Biorefineries B.V. Wholly Owned Subsidiary Interest received Omnibus Approval 1.43 0.00 0.00
53 Godavari Biorefineries B.V. Prajesh Mistry Director of Wos Remuneration NA 110.70 0.00 0.00
54 Godavari Biorefineries B.V. C W Faber Director of Wos Remuneration NA 7.11 0.00 0.00
55 Godavari Biorefineries INC. Arup Mitra Director of Wos Remuneration NA 28.91 0.00 0.00
56 Solar Magic Pvt Ltd Dharmil Seth Director of Wos Any other transaction Director Sitting Fees Omnibus Approval 0.10 0.00 0.00
57 Godavari Biorefineries B.V. Cayugs Investments B.V. Wholly Owned Subsidiary Dividend paid Omnibus Approval 26.06 0.00 26.06
Total value of transaction during the reporting period 4,855.99